Zobrazeno 1 - 10
of 48
pro vyhledávání: '"E. L Amelina"'
Autor:
L. R Avetisyan, M. Yu Chernukha, I. A Shaginyan, N. I Kapranov, E. A Siyanova, O. S Medvedeva, E. I Kondratieva, G. V Alekseeva, S. A Krasovsky, M. V Usacheva, E. L Amelina
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 92, Iss 6, Pp 3-10 (2015)
Aim. Study the spectrum of resistance to antibiotics and its variability of Staphylococcus aureus, Pseudomonas aeruginosa and Вurkholderia cepacia complex (BCC), persisting in lungs of MV patients. Materials and methods. 312 strains of S. aureus, 21
Externí odkaz:
https://doaj.org/article/5481061f862c42e7ad083c02641e1c2f
Autor:
E. I. Kondratyeva, A. I. Tlif, A. Yu. Voronkova, E. L. Amelina, N. Yu. Kashirskaya, S. A. Krasovsky, M. A. Starinova, T. L. Kuraeva
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 418-426 (2023)
BACKGROUND: In recent decades, the life expectancy of patients with CF has increased, which leads to an increase in the frequency of conditions associated with impaired carbohydrate metabolism.AIM: to analyze the impact of cystic fibrosis-associated
Externí odkaz:
https://doaj.org/article/12a6b36fd78d452fba1270a44826dc92
Autor:
E. I. Kondratieva, S. V. Trishina, A. V. Yurieva, N. V. Komlev, V. A. Tanaga, V. A. Terentiev, A. Yu. Voronkova, E. L. Amelina, A. V. Chernyak, S. A. Krasovskiy, V. Yu. Brisin, M. M. Khachiyan, E. V. Vodovozova, E. A. Enina, L. N. Ledeneva, E. T. Yagubyants, M. M. Chepurnaya
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 108-119 (2022)
Introduction. Cystic fibrosis (CF) is a hereditary disease with genetic heterogeneity and clinical polymorphism. Expanding the range of knowledge about the characteristics of the course of the disease in different regions is important to achieve the
Externí odkaz:
https://doaj.org/article/bb59d1bd922144f289478f54bb633000
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 48-53 (2019)
Among diseases of ENT organs at patients with the CF prevails chronic rhinosinusitis. Stagnation of the infected dense slime in the paranasal sinus and violation of nasal breath aggravates weight of a course of lung pathology. Timely inspection and t
Externí odkaz:
https://doaj.org/article/2c2868767e6640fdb06999b99bf5bb01
Autor:
S. A. Krasovsky, E. L. Amelina, A. V. Chernyak, E. I. Kondratieva, J. V. Gorinova, O. G. Zonenko, D. F. Sergienko, A. R. Tatarsky
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 72-77 (2019)
A non-interventional prospective cohort study was conducted on adult patients with cystic fibrosis, who received mucolytic therapy with 7% NaCl solution combined with 0.1% hyaluronic acid (medical product Hyaneb) and 7% NaCl solution for 4 and 8 week
Externí odkaz:
https://doaj.org/article/b1391bb682a840169a28d588d7ea2e3b
Autor:
S. A. Krasovskiy, E. L. Amelina, U. V. Gorinova, A. V. Chernyak, M. V. Afanasjeva, N. A. Krilova, G. L. Shumkova, O. G. Zonenko, A. R. Tatarskiy
Publikováno v:
Клиническая практика, Vol 9, Iss 4, Pp 25-32 (2018)
Background: Evaluation of the main clinical and functional indicators and their relationship with the treatment and diagnostic care at different time periods can contribute to the development of further effective medical strategies and globally lead
Externí odkaz:
https://doaj.org/article/7c5d6f8496d34e43b1c92b494f6e0c73
Autor:
E. I. Kondratyeva, A. Yu. Voronkova, N. Yu. Kashirskaya, S. A. Krasovsky, M. A. Starinova, E. L. Amelina, S. N. Avdeev, S. I. Kutsev
Publikováno v:
PULMONOLOGIYA. 33:171-181
A registry of patients with cystic fibrosis (CF) of the Russian Federation has been compiled annually since 2011. Analysis of the national registry with large amounts of clinical and laboratory data helps understand changes in demographic indicators,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5782626d9492675e536014f2d3bd8cb6
https://doi.org/10.18093/0869-0189-2023-33-2-171-181
https://doi.org/10.18093/0869-0189-2023-33-2-171-181
Autor:
N A Krylova, E L Amelina, S A Krasovsky, N A Karchevskaya, E A Tarabrin, A M Gasanov, D F Ibragimova, S V Golovinsky
Publikováno v:
Терапевтический архив, Vol 89, Iss 12, Pp 51-55 (2017)
Aim. To evaluate the efficiency of nocturnal hyperalimentation in adult patients with cystic fibrosis (CF) and respiratory failure. Subjects and methods. The investigation enrolled 17 patients older than 18 years (mean age, 25.6±4.2 years) diagnosed
Externí odkaz:
https://doaj.org/article/3fda5702636446049a7e5e604a064977
Autor:
I. A. Shaginyan, M. Yu. Chernukha, L. R. Avetisyan, E. A. Siyanova, D. G. Kulyastova, O. S. Medvedeva, T. B. Priputnevich, D. Yu. Trofimov, A. V. Gordeev, E. I. Kondratieva, E. L. Amelina, S. A. Krasovskiy
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 16, Iss 6, Pp 5-13 (2017)
Relevance. Life expectancy of cystic fibrosis patients mostly depends on the degree of respiratory system damage caused by opportunistic microorganisms, which is due to the fact that 90-95% of deaths of cystic fibrosis patients are caused by lung inf
Externí odkaz:
https://doaj.org/article/23b2824b74614215b0d1ef49fb034791
Publikováno v:
PULMONOLOGIYA. 32:737-744
Multidrug resistance of pulmonary pathogens in patients with cystic fibrosis (CF) requires new therapeutic solutions.The aim. To assess the effect of ceftazidime/avibactam (cef/avi) on clinical outcomes of pulmonary exacerbation of cystic fibrosis.Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9428369a5d21b66e31a9f86e0298b5e0
https://doi.org/10.18093/0869-0189-2022-32-5-737-744
https://doi.org/10.18093/0869-0189-2022-32-5-737-744